Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,124 GBX | -0.54% | +0.62% | +14.17% |
10:00am | AstraZeneca cancer treatment Tagrisso recommended for approval in EU | AN |
09:58am | AstraZeneca: conclusive trial for Enhertu in breast cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.17% | 240B | |
+40.73% | 739B | |
+31.74% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+9.18% | 210B | |
-5.24% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca to Build $1.5 Billion Cancer Therapy Manufacturing Facility in Singapore